Back to UBS Group AG UBS Group AG

CVACCVAC
Showing 7 of 23 quarters

Position history for UBS Group AGUBS Group AG's holdings in CUREVAC N V

UBS Group AG previously held 0 shares of CVAC (CUREVAC N V), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$175,442

Total Shares Change

-59,674

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$4.66
0
2025-Q4
Decreased
64,879
-83.8%
$293,2530.0%$4.48
0
2025-Q3
Increased
401,269
+65.8%
$2.2M0.0%$5.35
38
2025-Q2
Decreased
242,090
-71.3%
$1.3M0.0%$5.38
0
2025-Q1
Increased
843,193
+46.2%
$2.3M0.0%$2.98
36
2024-Q4
Increased
576,897
+866.8%
$2M0.0%$3.12
42
2024-Q3
Decreased
59,674
-47.2%
$175,4420.0%$3.00
0

Other major holders of CVAC: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used